EVOGENE LTD (EVGN) Stock Income Statement
NASDAQ:EVGN - Nasdaq - IL0011050551 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.76M | 8.51M | 5.64M | 1.68M | 930.00K | |||
| Minority Interest Expense | 1.99M | 1.57M | 2.08M | 3.21M | 2.65M | |||
| Cost Of Goods | 3.99M | 6.83M | 8.04M | 6.42M | 6.48M | |||
| Gross Profit | 2.78M | 1.68M | -2.40M | -4.75M | -5.55M | |||
| Operating Expenses | 25.21M | 23.34M | 24.12M | 25.58M | 25.31M | |||
| Research and Development | 15.05M | 9.50M | 11.26M | 12.51M | 12.93M | |||
| Selling, General, and Administrative Expenses | 10.16M | 11.35M | 10.46M | 11.25M | 10.81M | |||
| Operating Income | -22.44M | -21.66M | -26.52M | -30.32M | -30.86M | |||
| Interest Income/Expense | 5.06M | 808.00K | 933.00K | -2.45M | 980.00K | |||
| Other Income/Expense | 186.00K | 2.83M | -412.00K | 3.13M | -460.00K | |||
| Non Recurring Items | N/A | -21.00K | 16.00K | -120.00K | -90.00K | |||
| Income Before Taxes | -17.19M | -18.05M | -25.99M | -29.75M | -30.43M | |||
| Income Tax | 9.00K | 9.00K | -33.00K | 90.00K | 10.00K | |||
| Net Income | -15.21M | -16.48M | -23.88M | -26.64M | -27.79M | |||
| EBITDA | -20.03M | -19.16M | -23.91M | -27.74M | -28.63M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.69 | -2.89 | -5.23 | -0.65 | -0.69 | |||
| Non GAAP EPS | -2.69 | -3.11 | -5.30 | -6.40 | -6.90 | |||
| Statistics | ||||||||
| Gross Profit Margin | 41.06% | 19.69% | -42.57% | -282.74% | -596.77% | |||
| Profit Margin | -224.82% | -193.69% | -423.39% | -1585.71% | -2988.17% | |||
| Operating Profit Margin | -331.65% | -254.55% | -470.28% | -1804.76% | -3318.28% | |||
All data in USD